Donald Richieri Griffin

Donald Richieri Griffin is an Associate Professor in the Department of Biomedical Engineering at the University of Virginia and serves as the Graduate Program Director for Biomedical Engineering. His research focuses on developing biomaterials to enhance clinical translation of therapies, particularly through hydrogel-tissue integration. He holds a Ph.D. in Biomedical Engineering from UCLA and joined UVA in 2017. His work bridges academia and industry, with patents and a co-founded company, Tempo Therapeutics.

Education:

• Ph.D. in Biomedical Engineering, UCLA, 2011
• B.S. in Biomedical Engineering, UC Davis, 2006

Research Interests:

• Novel Biomaterial Development
• Drug and Cell Delivery
• Regenerative Medicine
• Tissue Engineering

Labs: Griffin Lab, focusing on advanced biomaterials for tissue regeneration and clinical applications. His lab's innovations include microporous annealed particle (MAP) gels, which modulate immune responses and support tissue repair.

Awards/Grants: No specific awards listed, but recognized for industry collaborations and patent activity. His research has been highlighted in news articles on fibrosis prevention and vocal cord regeneration.